Bayer Proposes $7.25 Billion Roundup Settlement
Bayer and plaintiffs proposed a $7.25 billion fund to resolve thousands of U.S. Roundup cancer claims, with payments spread over up to 21 years and requiring court approval.
Overview
Bayer and attorneys for cancer patients announced a proposed $7.25 billion settlement Tuesday to resolve thousands of U.S. lawsuits alleging Roundup caused non-Hodgkin lymphoma, and filed the deal in St. Louis Circuit Court.
The proposed settlement was announced as the U.S. Supreme Court prepares to hear arguments in April over whether EPA approval preempts state failure-to-warn claims, and the settlement would not affect that case.
Bayer disputed that glyphosate causes non-Hodgkin lymphoma, CEO Bill Anderson said the deal provides a road to closure, and attorney Christopher Seeger said it ensures patients access to meaningful compensation.
More than 125,000 plaintiffs have sued since 2015, Bayer said it has resolved more than 130,000 claims, faces about 65,000 more, and has previously paid roughly $10 billion to resolve litigation.
The settlement requires St. Louis Circuit Court approval and would fund annual payments for up to 21 years, while Bayer reserves the right to cancel if too many plaintiffs opt out.
Analysis
Center-leaning sources present this coverage neutrally, balancing corporate statements and regulatory findings while emphasizing factual litigation details. They cite Bayer's denials, IARC's classification, EPA disagreement, settlement figures, claim counts and eligibility rules, avoiding loaded judgments and allowing readers to weigh legal, scientific and financial aspects.
Sources (4)
FAQ
Bayer has paid out nearly $11 billion in Roundup lawsuit settlements since the initial 2020 settlement agreement[6]. Additionally, the company has faced over $6 billion in verdicts from successful trials since October 2023[6]. This new $7.25 billion settlement represents an additional commitment on top of amounts already paid.
Bayer's initial 2020 settlement for approximately $10 billion was abandoned due to legal challenges concerning the claims process[2]. The new $7.25 billion settlement addresses this by allowing claims to be filed over a period of up to 21 years and is designed to cover both current and future claims involving Roundup exposure before the settlement date, providing broader coverage than the previous agreement[5].
History
This story does not have any previous versions.